Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer||
||Other / NIH||
||37||Female||18 Years and older (Adult, Older Adult)||NCT01225887||GOG-0229K
|October 2011||January 2016||January 2016||October 21, 2010||October 9, 2017||October 9, 2017||